SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$0.50
-0.05 (-9.31%)
Open$0.59
Previous Close$0.55
Day High$0.59
Day Low$0.46
52W High$22.36
52W Low$0.46
Volume—
Avg Volume175.7K
Market Cap2.03M
P/E Ratio—
EPS$-12.44
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+7,165.4% upside
Current
$0.50
$0.50
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.24M | 2.11M | 2.20M |
| Net Income | -331,103 | -245,653 | -236,110 |
| Profit Margin | -14.8% | -11.6% | -10.7% |
| EBITDA | -455,957 | -486,512 | -478,296 |
| Free Cash Flow | -187,144 | -193,211 | -204,399 |
| Rev Growth | -3.1% | +9.8% | -1.4% |
| Debt/Equity | 0.51 | 0.41 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |